<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24577" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Lymphogranuloma Venereum</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rawla</surname>
            <given-names>Prashanth</given-names>
          </name>
          <aff>Sovah Health, Martinsville, VA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Thandra</surname>
            <given-names>Krishna C.</given-names>
          </name>
          <aff>Chesapeake Regional Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Limaiem</surname>
            <given-names>Faten</given-names>
          </name>
          <aff>University of Tunis El Manar, Tunis Faculty of Medicine</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Prashanth Rawla declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Krishna Thandra declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Faten Limaiem declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>31</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24577.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Lymphogranuloma venereum is an ulcerative sexually transmitted infection of the genital area caused by Chlamydia trachomatis that is transmittable by vaginal, oral or anal sex. This activity describes the etiology, epidemiology, pathophysiology, evaluation, and management of Lymphogranuloma venereum and highlights the role of the interprofessional team in evaluating and treating patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the pathophysiology of lymphogranuloma venereum.</p></list-item><list-item><p>Outline the typical presentation of a patient with lymphogranuloma venereum.</p></list-item><list-item><p>Review treatment considerations for patients with lymphogranuloma venereum.</p></list-item><list-item><p>Describe the importance of collaboration and communication amongst interprofessional team members to enhance the delivery of care for patients affected by lymphogranuloma venereum.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24577&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24577">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24577.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lymphogranuloma venereum&#x000a0;(LGV) is an ulcerative disease of the genital area.<xref ref-type="bibr" rid="article-24577.r1">[1]</xref> Its cause is the gram-negative bacteria <italic toggle="yes">Chlamydia trachomatis</italic>, especially serovars L1, L2, and L3.<xref ref-type="bibr" rid="article-24577.r2">[2]</xref> It is an&#x000a0;uncommon, sexually transmitted infection. It is transmittable by vaginal, oral or anal sex. There are increasing numbers of reports in men who have sex with men.<xref ref-type="bibr" rid="article-24577.r3">[3]</xref><xref ref-type="bibr" rid="article-24577.r4">[4]</xref></p>
        <p>Characteristically, lymphogranuloma venereum has three stages of infection&#x000a0;<xref ref-type="bibr" rid="article-24577.r1">[1]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p>Primary stage characterized by the development of painless genital ulcer or papules.</p>
          </list-item>
          <list-item>
            <p>Secondary stage with the&#x000a0;development of unilateral or bilateral tender inguinal and/or femoral lymphadenopathy (also called buboes).</p>
          </list-item>
          <list-item>
            <p>Late stage&#x000a0;with strictures, fibrosis, and fistulae of the anogenital area.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24577.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The causative agent is&#x000a0;<italic toggle="yes">Chlamydia trachomatis</italic>, serovars L1, L2, L3.<xref ref-type="bibr" rid="article-24577.r5">[5]</xref> Chlamydia is a&#x000a0;ubiquitous ovoid&#x000a0;or obligate intracellular bacteria.</p>
      </sec>
      <sec id="article-24577.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Lymphogranuloma venereum&#x000a0;is common in the tropical and subtropical regions around the world.&#x000a0;It is rare in the United States.<xref ref-type="bibr" rid="article-24577.r6">[6]</xref> Lymphogranuloma venereum may occur at any age; however,&#x000a0;the highest incidence of LGV is in the sexually active population between 15 and 40 years. Lymphogranuloma venereum probably affects both sexes equally although it is more commonly reported in men because early manifestations of LGV are more apparent in men.<xref ref-type="bibr" rid="article-24577.r7">[7]</xref> It is endemic&#x000a0;to men who have sex with men. There is a significant&#x000a0;association between HIV-infected patients and LGV.<xref ref-type="bibr" rid="article-24577.r8">[8]</xref> Men typically present with the acute form of the disease whereas women often present when they develop complications from later stages of the disease.<xref ref-type="bibr" rid="article-24577.r7">[7]</xref></p>
      </sec>
      <sec id="article-24577.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Lymphogranuloma venereum primarily affects&#x000a0;the lymphatic&#x000a0;system. <italic toggle="yes">Chlamydia trachomatis</italic> serovars extend&#x000a0;from the primary infection site to the regional lymph nodes and cause a lymphoproliferative reaction, facilitated by binding of <italic toggle="yes">Chlamydia&#x000a0;trachomatis</italic>&#x000a0;to the epithelial cells. Binding occurs via heparin sulfate receptors.<xref ref-type="bibr" rid="article-24577.r9">[9]</xref></p>
      </sec>
      <sec id="article-24577.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>
<bold>Lymph nodes:</bold>
</p>
        <p>Tiny necrotic foci infiltrated by neutrophils represent the earliest microscopic change in an affected node. These enlarge and coalesce to form the stellate abscess that represents the most characteristic feature of this disease. In later stages, epithelioid cells scattered Langhans giant cells, and fibroblasts are seen to line the abscess walls. Confluence of these abscesses is common, and cutaneous sinus tracts may develop. Nodules with dense fibrous walls surrounding amorphous material represent the healing stage.<xref ref-type="bibr" rid="article-24577.r1">[1]</xref></p>
        <p>
<bold>Rectal biopsies:</bold>
</p>
        <p>Histopathologic examination of rectal biopsies in patients with LGV proctitis usually reveals&#x000a0;severe inflammatory changes, and these have been misattributed to inflammatory bowel disease in recent years. Histopathologists should consider LGV in the differential diagnosis when reporting on inflammatory rectal biopsy specimens as a relevant risk behavior might not be provided in the clinical history accompanying the specimen.<xref ref-type="bibr" rid="article-24577.r1">[1]</xref></p>
      </sec>
      <sec id="article-24577.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Evaluation should involve a thorough history including a sexual history.</p>
        <p>Characteristically lymphogranuloma venereum has three&#x000a0;stages&#x000a0;<xref ref-type="bibr" rid="article-24577.r10">[10]</xref>:</p>
        <p>
<bold>Primary Stage</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Begins in 3 to 12 days after exposure or sometimes it may be longer up to&#x000a0;30 days.</p>
          </list-item>
          <list-item>
            <p>The patient characteristically develops a painless genital ulcer or papules which&#x000a0;are about 1 to 6 mm in size. Sores can also be present in the mouth or throat. An inflammatory reaction can occur at the site of inoculation.</p>
          </list-item>
          <list-item>
            <p>This stage often goes unnoticed&#x000a0;due to&#x000a0;the location of the lesions and as the lesions are usually small and there&#x000a0;are no associated symptoms.</p>
          </list-item>
          <list-item>
            <p>The lesions resolve or heal spontaneously after few days.</p>
          </list-item>
        </list>
        <p>
<bold>Secondary Stage</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>The secondary stage presents with the development of unilateral or bilateral tender inguinal and/or femoral lymphadenopathy (also called buboes), which occurs two to six weeks after the primary stage; this is called&#x000a0;the inguinal syndrome.</p>
          </list-item>
          <list-item>
            <p>An anorectal syndrome also presents which&#x000a0;is&#x000a0;characterized&#x000a0;by proctitis or proctocolitis-like symptoms. Pain during urination, rectal bleeding, pain during passing stools, abdominal pain, anal pain, tenesmus. Generalized symptoms like body aches, headache, and fever can occur during this stage.&#x000a0; This syndrome usually occurs when the transmission is via the anal route.<xref ref-type="bibr" rid="article-24577.r11">[11]</xref></p>
          </list-item>
          <list-item>
            <p>An oral syndrome can occur in people get LGV through the oral route. Cervical lymphadenopathy can occur.</p>
          </list-item>
          <list-item>
            <p>There are also reports of systemic complications like pneumonia and hepatitis.<xref ref-type="bibr" rid="article-24577.r12">[12]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Late Sequelae</bold>
</p>
        <p>Usually, occur when the disease is left untreated.</p>
        <list list-type="bullet">
          <list-item>
            <p>Necrosis and rupture of the lymph nodes</p>
          </list-item>
          <list-item>
            <p>Anogenital fibrosis, and strictures</p>
          </list-item>
          <list-item>
            <p>Anal fistulae</p>
          </list-item>
          <list-item>
            <p>Elephantiasis of the genital organs can also occur in some cases</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24577.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis&#x000a0;is by clinical suspicion. Other causes of genital ulceration and inguinal adenopathy should be excluded.<xref ref-type="bibr" rid="article-24577.r13">[13]</xref></p>
        <p>The basis for a definitive diagnosis of LGV&#x000a0;is on serology tests (complement fixation or micro-immunofluorescence) or identification of Chlamydia trachomatis in&#x000a0;genital, rectal and lymph node specimens (by culture, nucleic acid amplification test or direct immunofluorescence).<xref ref-type="bibr" rid="article-24577.r14">[14]</xref></p>
        <p>Men who have sex with men who have signs and symptoms of proctocolitis should receive testing for LGV. In these patients testing of rectal specimens with&#x000a0;nucleic acid amplification test is the preferred approach.<xref ref-type="bibr" rid="article-24577.r15">[15]</xref><xref ref-type="bibr" rid="article-24577.r14">[14]</xref></p>
        <p>HIV testing should be a consideration in patients with a sexually transmitted infection.</p>
      </sec>
      <sec id="article-24577.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>The recommended treatment regimen is doxycycline 100 mg orally twice a day given for 21 days.<xref ref-type="bibr" rid="article-24577.r16">[16]</xref></p>
        <p>An alternate regimen is erythromycin 500 mg orally four times a day given for 21 days.</p>
        <p>Azithromycin 1 gm orally once weekly for 3 weeks is also an effective alternative regimen.<xref ref-type="bibr" rid="article-24577.r2">[2]</xref></p>
        <p>All patients who are suspected to have LGV (either genito-ulcerative&#x000a0;disease with lymphadenopathy or proctocolitis) should be empirically treated&#x000a0;for LGV before an official diagnosis is certain.</p>
        <p>Pregnant patients can have treatment with erythromycin. Doxycycline and other tetracyclines should be avoided in pregnancy due to the risk of disruption of bone and teeth development.</p>
        <p>Patients who have fluctuant&#x000a0;or pus-filled&#x000a0;buboes can benefit from aspiration of the node, which provides symptomatic relief, although incision and drainage of the nodes&#x000a0;are&#x000a0;not recommended as it can delay the healing process.<xref ref-type="bibr" rid="article-24577.r17">[17]</xref></p>
      </sec>
      <sec id="article-24577.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Sexually transmitted&#x000a0;infections are the first to consider in the differential diagnosis of LGV.</p>
        <p>The exclusion of diseases which cause genital ulceration and inguinal adenopathy&#x000a0;including herpes simplex, syphilis, chancroid, herpes, and&#x000a0;granuloma inguinale will help narrow the diagnosis.&#x000a0;</p>
        <p>HIV and lymphoma can also cause generalized lymphadenopathy.</p>
        <p>Dermatological conditions and trauma which can cause genital ulcerations should also be in the differential diagnosis.</p>
      </sec>
      <sec id="article-24577.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Prognosis is fair if recognized and treated early.</p>
      </sec>
      <sec id="article-24577.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications usually occur&#x000a0;when the disease&#x000a0;is left&#x000a0;untreated &#x02014; necrosis and rupture of the lymph nodes, anogenital fibrosis, and strictures, anal fistulae.&#x000a0;Elephantiasis of the genital organs can also occur&#x000a0;in some cases.&#x000a0;Systemic complications like pneumonia and hepatitis also have&#x000a0;been reported.<xref ref-type="bibr" rid="article-24577.r18">[18]</xref></p>
      </sec>
      <sec id="article-24577.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>In difficult to diagnose and treat cases and infectious disease consultation may&#x000a0;be warranted.</p>
        <p>Surgical consultation is needed for tertiary or late-stage disease if complications like fistulas or strictures cause damage to the anorectal area.</p>
      </sec>
      <sec id="article-24577.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients should receive education regarding the signs and symptoms of early recognition of LGV. Having LGV can increase a patients risk of contracting other&#x000a0;sexually transmitted&#x000a0;infections like HIV, hepatitis, syphilis, chancroid, gonorrhea, etc. Patients should learn about the need to use condoms or other protective measures while engaging in sexual activity. Sexual partners of patients&#x000a0;who tested positive or probably positive should also be tested, and treatment initiated if necessary. Men who have sex with men should recognize that LGV is prevalent in these populations and should know the signs and symptoms of LGV.</p>
      </sec>
      <sec id="article-24577.s15" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>
<bold>Management of Sexual Partners of LGV Patients:</bold>
</p>
        <p>All exposed partners of LGV probable or confirmed patients in the&#x000a0;last 60 days should receive testing and empiric treatment with a chlamydial regimen (doxycycline 100mg PO BID for 7 days or 1gm azithromycin one-time dose). Appropriate testing should be done based on the route of transmission and can include&#x000a0;either cervical, urethral or rectal specimens. If testing for chlamydia and/or LGV comes back positive, then treatment&#x000a0;should&#x000a0;be continued&#x000a0;to complete a 21-day course. If testing is negative for chlamydia or LGV, then treatment should cease after 7 days.</p>
        <p>A diagnosis of LGV should be taken into consideration by gastroenterologists and histologists in patients presenting with proctitis or inguinal lymphadenopathy, particularly in men who have sex with men.<xref ref-type="bibr" rid="article-24577.r19">[19]</xref></p>
      </sec>
      <sec id="article-24577.s16" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Treatment of LGV affected patients and the recognition of potentially exposed partners requires a coordinated effort from the physicians and nursing staff. Physicians&#x000a0;and nurses should educate the patients on the early recognition of signs and symptoms of LGV and other STDs and encourage to seek treatment early to improve outcomes and prevent and complications. Pharmacists should recognize the different medications used for the treatment of LGV and their complications and educate the patients&#x000a0;including the risks and benefits of&#x000a0;usage of these medications in pregnancy and lactation. an interprofessional&#x000a0;approach will provide the best long-term results for these patients. [Level V]</p>
      </sec>
      <sec id="article-24577.s17">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24577&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24577">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/sexual-health/lymphogranuloma-venereum/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24577">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24577/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24577">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24577.s18">
        <fig id="article-24577.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Lymphogranuloma venereum Image courtesy S Bhimji MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="LGV" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24577.s19">
        <fig id="article-24577.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Lymphogranuloma venereum proctocolitis - Differential Diagnosis Created by Marc Daniel Sheinman, DO</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="LGV__Differential" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24577.s20">
        <title>References</title>
        <ref id="article-24577.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mabey</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Peeling</surname>
                <given-names>RW</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma venereum.</article-title>
            <source>Sex Transm Infect</source>
            <year>2002</year>
            <month>Apr</month>
            <volume>78</volume>
            <issue>2</issue>
            <fpage>90</fpage>
            <page-range>90-2</page-range>
            <pub-id pub-id-type="pmid">12081191</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Workowski</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Bolan</surname>
                <given-names>GA</given-names>
              </name>
              <collab>Centers for Disease Control and Prevention</collab>
            </person-group>
            <article-title>Sexually transmitted diseases treatment guidelines, 2015.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2015</year>
            <month>Jun</month>
            <day>05</day>
            <volume>64</volume>
            <issue>RR-03</issue>
            <fpage>1</fpage>
            <page-range>1-137</page-range>
            <pub-id pub-id-type="pmid">26042815</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Blank</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Schillinger</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Harbatkin</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma venereum in the industrialised world.</article-title>
            <source>Lancet</source>
            <year>2005</year>
            <month>May</month>
            <day>7-13</day>
            <volume>365</volume>
            <issue>9471</issue>
            <fpage>1607</fpage>
            <page-range>1607-8</page-range>
            <pub-id pub-id-type="pmid">15885284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nieuwenhuis</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Ossewaarde</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>G&#x000f6;tz</surname>
                <given-names>HM</given-names>
              </name>
              <name>
                <surname>Dees</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Thio</surname>
                <given-names>HB</given-names>
              </name>
              <name>
                <surname>Thomeer</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>den Hollander</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Neumann</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>van der Meijden</surname>
                <given-names>WI</given-names>
              </name>
            </person-group>
            <article-title>Resurgence of lymphogranuloma venereum in Western Europe: an outbreak of Chlamydia trachomatis serovar l2 proctitis in The Netherlands among men who have sex with men.</article-title>
            <source>Clin Infect Dis</source>
            <year>2004</year>
            <month>Oct</month>
            <day>01</day>
            <volume>39</volume>
            <issue>7</issue>
            <fpage>996</fpage>
            <page-range>996-1003</page-range>
            <pub-id pub-id-type="pmid">15472852</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spaargaren</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fennema</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Morr&#x000e9;</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>de Vries</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Coutinho</surname>
                <given-names>RA</given-names>
              </name>
            </person-group>
            <article-title>New lymphogranuloma venereum Chlamydia trachomatis variant, Amsterdam.</article-title>
            <source>Emerg Infect Dis</source>
            <year>2005</year>
            <month>Jul</month>
            <volume>11</volume>
            <issue>7</issue>
            <fpage>1090</fpage>
            <page-range>1090-2</page-range>
            <pub-id pub-id-type="pmid">16022786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Stephens</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Trachoma and LGV biovars of Chlamydia trachomatis share the same glycosaminoglycan-dependent mechanism for infection of eukaryotic cells.</article-title>
            <source>Mol Microbiol</source>
            <year>1994</year>
            <month>Feb</month>
            <volume>11</volume>
            <issue>3</issue>
            <fpage>501</fpage>
            <page-range>501-7</page-range>
            <pub-id pub-id-type="pmid">8152374</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ceovic</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gulin</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma venereum: diagnostic and treatment challenges.</article-title>
            <source>Infect Drug Resist</source>
            <year>2015</year>
            <volume>8</volume>
            <fpage>39</fpage>
            <page-range>39-47</page-range>
            <pub-id pub-id-type="pmid">25870512</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>R&#x000f6;nn</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>The association between lymphogranuloma venereum and HIV among men who have sex with men: systematic review and meta-analysis.</article-title>
            <source>BMC Infect Dis</source>
            <year>2011</year>
            <month>Mar</month>
            <day>18</day>
            <volume>11</volume>
            <fpage>70</fpage>
            <pub-id pub-id-type="pmid">21418569</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Su</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Raymond</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Rockey</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Fischer</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hackstadt</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Caldwell</surname>
                <given-names>HD</given-names>
              </name>
            </person-group>
            <article-title>A recombinant Chlamydia trachomatis major outer membrane protein binds to heparan sulfate receptors on epithelial cells.</article-title>
            <source>Proc Natl Acad Sci U S A</source>
            <year>1996</year>
            <month>Oct</month>
            <day>01</day>
            <volume>93</volume>
            <issue>20</issue>
            <fpage>11143</fpage>
            <page-range>11143-8</page-range>
            <pub-id pub-id-type="pmid">8855323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dal Conte</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mistrangelo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Cariti</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chiriotto</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lucchini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vigna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Morino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Di Perri</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma venereum: an old, forgotten re-emerging systemic disease.</article-title>
            <source>Panminerva Med</source>
            <year>2014</year>
            <month>Mar</month>
            <volume>56</volume>
            <issue>1</issue>
            <fpage>73</fpage>
            <page-range>73-83</page-range>
            <pub-id pub-id-type="pmid">24518282</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Harrison</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Som</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Stroup</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma venereum proctitis.</article-title>
            <source>Proc (Bayl Univ Med Cent)</source>
            <year>2016</year>
            <month>Oct</month>
            <volume>29</volume>
            <issue>4</issue>
            <fpage>418</fpage>
            <page-range>418-419</page-range>
            <pub-id pub-id-type="pmid">27695183</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schachter</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Chlamydial infections.</article-title>
            <source>West J Med</source>
            <year>1990</year>
            <month>Nov</month>
            <volume>153</volume>
            <issue>5</issue>
            <fpage>523</fpage>
            <page-range>523-34</page-range>
            <pub-id pub-id-type="pmid">2260289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <collab>Centers for Disease Control and Prevention</collab>
            <article-title>Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae--2014.</article-title>
            <source>MMWR Recomm Rep</source>
            <year>2014</year>
            <month>Mar</month>
            <day>14</day>
            <volume>63</volume>
            <issue>RR-02</issue>
            <fpage>1</fpage>
            <page-range>1-19</page-range>
            <pub-id pub-id-type="pmid">24622331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bachmann</surname>
                <given-names>LH</given-names>
              </name>
              <name>
                <surname>Johnson</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Papp</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Palella</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Hook</surname>
                <given-names>EW</given-names>
              </name>
            </person-group>
            <article-title>Nucleic acid amplification tests for diagnosis of Neisseria gonorrhoeae and Chlamydia trachomatis rectal infections.</article-title>
            <source>J Clin Microbiol</source>
            <year>2010</year>
            <month>May</month>
            <volume>48</volume>
            <issue>5</issue>
            <fpage>1827</fpage>
            <page-range>1827-32</page-range>
            <pub-id pub-id-type="pmid">20335410</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Meyer</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Diagnostic Procedures to Detect Chlamydia trachomatis Infections.</article-title>
            <source>Microorganisms</source>
            <year>2016</year>
            <month>Aug</month>
            <day>05</day>
            <volume>4</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">27681919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Handsfield</surname>
                <given-names>HH</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma Venereum Treatment and Terminology.</article-title>
            <source>Sex Transm Dis</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>409</fpage>
            <page-range>409-411</page-range>
            <pub-id pub-id-type="pmid">29642122</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>White</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>O'Farrell</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Daniels</surname>
                <given-names>D</given-names>
              </name>
              <collab>British Association for Sexual Health and HIV</collab>
            </person-group>
            <article-title>2013 UK National Guideline for the management of lymphogranuloma venereum: Clinical Effectiveness Group of the British Association for Sexual Health and HIV (CEG/BASHH) Guideline development group.</article-title>
            <source>Int J STD AIDS</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>24</volume>
            <issue>8</issue>
            <fpage>593</fpage>
            <page-range>593-601</page-range>
            <pub-id pub-id-type="pmid">23970591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stoner</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>SE</given-names>
              </name>
            </person-group>
            <article-title>Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment.</article-title>
            <source>Clin Infect Dis</source>
            <year>2015</year>
            <month>Dec</month>
            <day>15</day>
            <volume>61 Suppl 8</volume>
            <fpage>S865</fpage>
            <page-range>S865-73</page-range>
            <pub-id pub-id-type="pmid">26602624</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24577.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>IM</given-names>
              </name>
              <name>
                <surname>Alexander</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Ison</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Macdonald</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>McCarthy</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis of lymphogranuloma venereum from biopsy samples.</article-title>
            <source>Gut</source>
            <year>2006</year>
            <month>Oct</month>
            <volume>55</volume>
            <issue>10</issue>
            <fpage>1522</fpage>
            <page-range>1522-3</page-range>
            <pub-id pub-id-type="pmid">16966707</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
